# Combination Chemotherapy in Treating Patients With Stage III Colon Cancer

> **NCT00003835** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 1260 (estimated)

## Conditions studied

- Adenocarcinoma of the Colon
- Stage III Colon Cancer

## Interventions

- **DRUG:** leucovorin calcium
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00003835
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** 2007-08
- **Final completion:** —
- **Target enrollment:** 1260 (ESTIMATED)
- **Last updated:** 2013-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003835, "Combination Chemotherapy in Treating Patients With Stage III Colon Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*